(P-1603) COVID-19 Case Attack Rate Differences by Vaccination Status and Vaccine Effectiveness among US Nursing Home Residents, October 5, 2024 to January 5, 2025

Wednesday, October 22, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Farid L. Khan, MPH (he/him/his)

Farid Khan, MPH CMD Global Real-World Evidence (RWE) Epidemiologic Scientist, COVID/RSV/Flu, Director
Pfizer
Collegeville, PA, United States

EZ

Evan Zasowski, PharmD

Global Scientific Affairs Director, COVID & Flu
Pfizer
New York, New York, United States
Angela Cook, MS (she/her/hers)

Global Scientific Affairs Manager, COVID-19 & Flu
Pfizer
Brooklyn, New York, United States
JB

Jenny Boucher, PharmD

US Medical Director, MRNA Vaccines
Pfizer
Collegeville, Pennsylvania, United States
TB

Tobias Bergroth, PhD

Global Scientific Affairs Director, COVID & Flu
Pfizer
Stockholm, Stockholms Lan, Sweden
SL

Santiago M.C. Lopez, MD

Pfizer Inc
Collegeville, Pennsylvania, United States
TW

Timothy L. Wiemken, PhD

Pfizer Inc
Saint Louis, Missouri, United States
LP

Laura A. Puzniak, PhD. MPH

Pfizer Inc.
Collegeville, Pennsylvania, United States